GENELINK (GNLK) TECHNOLOGYFEATURED IN INDUSTRY TRADE JOURNAL
April 9, 2002

Margate, NJ-(BUSINESS WIRE)-- April 9, 2002 - GeneLink BioSciences, Inc. (OTCBB:GNLK) announced today that it is featured in an article in Chemical & Engineering News, an industry trade journal for companies who supply basic ingredients and products to the cosmetic companies of the world. The article, titled DESIGNER COSMETICS, is in the Business section, dated March 25, 2002, under the subsection PERSONAL CARE. The article was written by Marc S. Reisch, Staff Writer for C& EN Northeast News Bureau and clearly describes how GeneLink's technology may be able to mastermind the most unique and avant-garde products in the Personal Care field. The author concludes, "If DNA variations determine the way in which drugs affect people, those same variations could account for how people respond to different skin care formulations. And so coming to a department store near you this fall or next spring could be a proprietary test that can determine the oxidative stress profile of a person's skin. At least that's Margate, N.J.-based GeneLink's plan."

For a complete copy of this informative article, click here. (PDF, 187K)

About GeneLink BioSciences, Inc.: GNLK is positioned to become a leading provider of genetic profiling technologies. It developed a proprietary method for "genetic profiling" (patents pending) and will begin licensing this breakthrough technology to companies that market or manufacture products for the $100 billion plus nutraceutical, skin care, wellness and weight-loss industries. GNLK has FDA clearance and a patent issued for its non-invasive DNA Collection Kit. Its DNA bank is located at the University of North Texas Health Science Center at Fort Worth, a 105 year old medical facility that guarantees the DNA storage.

Forward-Looking Statements: This press release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GNLK disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise.

SOURCE: GeneLink BioSciences, Inc.